IDIOTYPE-BEARING LYMPHOID CELLS IN PLASMA CELL NEOPLASIAMELLSTEDT H; HOLM G; PETTERSSON D et al.1982; CLIN. HAEMATOL.; ISSN 0308-2261; GBR; DA. 1982; VOL. 11; NO 1; PP. 65-86; BIBL. 3 P.Article

Thoraxröntgenbefunde bei erworbenem Antikörpermangelsyndrom mit chronisch granulomatöser EntzündungQAIYUMI, S. A. A; PEEST, D; GALANSKI, M et al.Röntgen-Blätter. 1990, Vol 43, Num 7, pp 288-291, issn 0300-8592Article

Anaphylaktoider Schock nach Alloferin = Choc anaphylactoïde après alloférine = Anaphylactoid shock after alloferinPANNING, B; PEEST, D; KIRCHNER, E et al.Der Anaesthesist (Berlin. Print). 1985, Vol 34, Num 4, pp 211-212, issn 0003-2417Article

A plasma clot culture system for growing and antiproliferative drug sensitivity testing of myeloma stem cells = Un système de culture en plasma coagulé pour la prolifération et le test de sensibilité des médicaments anti-prolifératifs des cellules souches de myélomeLUDWIG, H; FRITZ, E; PEEST, D et al.Leukemia research. 1984, Vol 8, Num 4, pp 701-711, issn 0145-2126Article

IDIOTYPE-BEARING PERIPHERAL BLOOD LYMPHOCYTES IN HUMAN MULTIPLE MYELOMA AND WALDENSTROEM'S MACROGLOBULINAEMIASCHEDEL I; PEEST D; STUNKEL K et al.1980; SCAND. J. IMMUNOL.; NOR; DA. 1980; VOL. 11; NO 4; PP. 437-444; BIBL. 29 REF.Article

In vitro immunoglobulin production by peripheral blood mononuclear cells from multiple myeloma patients and patients with benign monoclonal gammopathy: regulation by cell subsetsPEEST, D; BRUNKHORST, U; SCHEDEL, I et al.Scandinavian journal of immunology (Print). 1984, Vol 19, Num 2, pp 149-157, issn 0300-9475Article

The role of alpha-interferon in multiple myelomaPEEST, D.Pathologie et biologie. 1999, Vol 47, Num 2, pp 172-177, issn 0369-8114Conference Paper

T CELLS IN MONOCLONAL GAMMOPATHIESMELLSTEDT H; HOLM G; PETTERSSON D et al.1982; SCAND. J. HAEMATOL.; ISSN 0036-553X; DNK; DA. 1982; VOL. 29; NO 1; PP. 57-64; BIBL. 32 REF.Article

Serum antibodies against common antigens of bacterial lipopolysaccharides in healthy adults and in patients with multiple myelomaSTOLL, C; SCHEDEL, I; PEEST, D et al.Infection. 1985, Vol 13, Num 3, pp 115-119, issn 0300-8126Article

Effect of interleukin-2 on the ex vivo growth of human myeloma cellsPEEST, D; DE VRIES, I; HÖLSCHER, R et al.Cancer immunology and immunotherapy. 1989, Vol 30, Num 4, pp 227-232, issn 0340-7004Article

Cytostatic drug sensitivity test for human multiple myeloma, measuring monoclonal immunoglobulin produced by bone marrow cells in vitroPEEST, D; BARTELS, B; DALLMANN, I et al.Cancer chemotherapy and pharmacology. 1986, Vol 17, Num 1, pp 69-74, issn 0344-5704Article

Suppression of polyclonal B cell proliferation mediated by supernatants from human myeloma bone marrow cell culturesPEEST, D; HÖLSCHER, R; WEBER, R et al.Clinical and experimental immunology (Print). 1989, Vol 75, Num 2, pp 252-257, issn 0009-9104Article

VDAMDex chemotherapy in advanced multiple myelomaPEEST, D; SCHMOLL, H.-J; SCHEDEL, I et al.European journal of haematology. 1988, Vol 40, Num 3, pp 245-249, issn 0902-4441Article

Induction and maintenance therapy in multiple myeloma: a multicenter trial of MP versus VCMPPEEST, D; DEICHER, H; COLDEWEY, R et al.European journal of cancer & clinical oncology. 1988, Vol 24, Num 6, pp 1061-1067, issn 0277-5379Article

Prognostic relevance of a histologic classification system applied in bone marrow biopsies from patients with multiple myeloma : a histopathological evaluation of biopsies from 153 untreated patientsSAILER, M; VYKOUPIL, K.-F; PEEST, D et al.European journal of haematology. 1995, Vol 54, Num 3, pp 137-146, issn 0902-4441Article

Quantification of human urinary free secretory component, secretory and nonsecretory Ig A by ELISAFLOEGE, J; BOEDDEKER, M; DREIKHAUSEN, U et al.Clinical physiology and biochemistry. 1989, Vol 7, Num 3-4, pp 165-175, issn 0252-1164, 11 p.Article

High incidence of monoclonal immunoglobulins in patients after liver or heart transplantationPEEST, D; SCHAPER, B; NASHAN, B et al.Transplantation. 1988, Vol 46, Num 3, pp 389-393, issn 0041-1337Article

Regulation of the in vitro monoclonal immunoglobulin production in cultures of peripheral blood mononuclear cells and bone marrow cells from myeloma patients mediated by T cell dependent mitogensPEEST, D; GASCH, S; THIELE, C et al.Clinical and experimental immunology (Print). 1986, Vol 65, Num 1, pp 120-127, issn 0009-9104Article

Autoimmunity resulting from cytokine treatment predicts long-term survival in patients with metastatic renal cell cancerFRANZKE, A; PEEST, D; PROBST-KEPPER, M et al.Journal of clinical oncology. 1999, Vol 17, Num 2, pp 529-533, issn 0732-183XArticle

Cytokine therapy in multiple myelomaPEEST, D; BLADE, J; HAROUSSEAU, J.-L et al.British journal of haematology. 1996, Vol 94, Num 3, pp 425-432, issn 0007-1048Article

Multiparameter analyses of normal and malignant human plasma cells : CD38⁺⁺, CD56^+, CD56⁺, cIg⁺ is the common phenotype of myeloma cellsLEO, R; BOEKER, M; PEEST, D et al.Annals of hematology (Print). 1992, Vol 64, Num 3, pp 132-139, issn 0939-5555Article

Pyridinium cross-links in multiple myeloma : Correlation with clinical parameters and use for monitoring of intravenous clodronate therapy : A pilot study of the German Myeloma Treatment Group (GMTG)PEEST, D; DEICHER, H; SIECKE, H et al.European journal of cancer (1990). 1996, Vol 32, Num 12, pp 2053-2057, issn 0959-8049Article

Low-dose recombinant interleukin-2 therapy in advanced multiple myelomaPEEST, D; LEO, R; WACKER, H.-H et al.British journal of haematology. 1995, Vol 89, Num 2, pp 328-337, issn 0007-1048Article

Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma : A randomized multicenter studyÖSTERBORG, A; BOOGAERTS, M. A; CIMINO, R et al.Blood. 1996, Vol 87, Num 7, pp 2675-2682, issn 0006-4971Article

Effect of recombinant human erythropoietin after allogeneic bone marrow transplantationLINK, H; BRUNE, T; NICOLAY, U et al.Annals of hematology (Print). 1993, Vol 67, Num 4, pp 169-173, issn 0939-5555Article